Key result
Kcna3 deficiency raises systolic blood pressure by ~6 mmHg compared to wild-type controls.
Why the study?
The mechanisms linking ion channel dysfunction to hypertension remain poorly understood, and the role of the voltage-gated potassium channel Kv1.3 in the pathogenesis of hypertension is unclear.
Does Kcna3 deficiency increase blood pressure and renin expression in mice?
Does Kcna3 deficiency increase blood pressure and renin expression in mice?
Kv1.3 channel deficiency promotes renin-associated hypertension via a Ca2+-dependent AKT-PKA-CREB signaling axis, identifying a potential novel therapeutic target for hypertension.
Answers are grounded in this paper and cite their sources.
Kcna3 deficiency elevates BP via Ca2+-PKA-CREB-renin signaling in mice; leaves open Kv1.3 as human hypertension target.
Hypertension is an important risk factor for cardiovascular and renal diseases, yet the mechanisms linking ion channel dysfunction to hypertension remain poorly understood. The voltage-gated potassium channel Kv1.3 (encoded by Kcna3) regulates membrane potential, but its role in the pathogenesis of hypertension remains unclear. In this study, we employed Kcna3 knockout (KO) mice, transcriptomic profiling, and pharmacological inhibition to investigate the role of Kv1.3. Kcna3-deficient mice showed increased blood pressure and renal fibrosis. Transcriptomic profiling showed activation of the renin–angiotensin–aldosterone system (RAAS), with increased renin expression in both Kcna3-deficient mice and Kv1.3 inhibitor-treated cells. Mechanistically, loss of Kv1.3 increased intracellular Ca2+ accumulation, activating the phosphoinositide 3-kinase (PI3K)-AKT and protein kinase A (PKA) pathways, leading to cAMP response element binding protein (CREB) phosphorylation and Renin upregulation. Pharmacological inhibition of Ca2+ signaling or PKA reduced CREB phosphorylation and Renin expression, confirming a causal signaling cascade. Thus, Kv1.3 links membrane excitability to RAAS activation via a Ca2+-dependent AKT–PKA–CREB signaling axis and represents a potential therapeutic target for hypertension and associated renal injury.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied Hypertension (Preclinical model) (n=20). Kcna3 deficiency (knockout) vs. Wild-type (WT) littermates was evaluated on Systolic blood pressure, diastolic blood pressure, and mean arterial pressure (5-8 mmHg SBP elevation, p=<0.001). Kcna3 deficiency significantly elevated systolic blood pressure by 5-8 mmHg, diastolic blood pressure, and mean arterial pressure compared to wild-type mice (p<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: